EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Estimating the Risk of ABO Hemolytic Disease of the Newborn in Lagos

Alani Sulaimon Akanmu, Olufemi Abiola Oyedeji, Titilope Adenike Adeyemo, Ann Abiola Ogbenna

Journal of Blood Transfusion · 2015

DOI: 10.1155/2015/560738 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Blood Transfusion, 2015. Verfasst von Alani Sulaimon Akanmu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology & Blood Transfusion, Faculty of Clinical Sciences, College of Medicine, University of Lagos, PMB 12003, Lagos, Nigeria. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

ABO hemolytic disease of the newborn is the most common hemolytic consequence of maternofetal blood group incompatibility restricted mostly to non-group-O babies of group O mothers with immune anti-A or anti-B antibodies.

Aim

We estimated the risk of ABO HDN with view to determining need for routine screening for ABO incompatibility between mother and fetus. Materials and Methods . Prevalence of ABO blood group phenotypes in blood donors at the donor clinic of the Lagos University Teaching Hospital and arithmetic methods were used to determine population prevalence of ABO genes. We then estimated proportion of pregnancies of group O mothers carrying a non-group-O baby and the risk that maternofetal ABO incompatibility will cause clinical ABO HDN.

Results

Blood from 9138 donors was ABO typed. 54.3%, 23%, 19.4%, and 3.3% were blood groups O, A, B, and AB, respectively. Calculated gene frequencies were 0.1416, 0.1209, and 0.7375 for A, B, and O genes, respectively. It was estimated that 14.3% of deliveries will result in a blood group O woman giving birth to a child who is non-group-O. Approximately 4.3% of deliveries are likely to suffer ABO HDN with 2.7% prone to suffer from moderately severe to severe hemolysis.

Autor:innen und Institutionen

  • Department of Hematology & Blood Transfusion, Faculty of Clinical Sciences, College of Medicine, University of Lagos, PMB 12003, Lagos, Nigeria.

Zitieren

APA

Akanmu, A. S., Oyedeji, O. A., Adeyemo, T. A., & Ogbenna, A. A. (2015). Estimating the Risk of ABO Hemolytic Disease of the Newborn in Lagos. Journal of Blood Transfusion. https://doi.org/10.1155/2015/560738

Vancouver

Akanmu AS, Oyedeji OA, Adeyemo TA, Ogbenna AA. Estimating the Risk of ABO Hemolytic Disease of the Newborn in Lagos. Journal of Blood Transfusion. 2015. doi:10.1155/2015/560738

BibTeX
@article{Akanmu2015,
  author = {Akanmu, Alani Sulaimon and Oyedeji, Olufemi Abiola and Adeyemo, Titilope Adenike and Ogbenna, Ann Abiola},
  title = {Estimating the Risk of ABO Hemolytic Disease of the Newborn in Lagos},
  journal = {Journal of Blood Transfusion},
  year = {2015},
  doi = {10.1155/2015/560738}
}
Kostenlos starten →